UnitedHealth Group Incorporated
- UnitedHealth Group declined 9.1% to $549.99 after the health insurer reported higher-than-expected medical costs.
Revenue in the third quarter increased to $100.8 billion from $92.4 billion, net income attributable to shareholders advanced to $6.1 billion from $5.8 billion, and diluted earnings per share rose to $7.15 from $6.56 a year ago.
Medical costs jumped to $66 billion from $59.6 billion, and total operating costs rose to $92.1 billion from $83.8 billion a year ago.
The company lowered its full-year net income per share outlook to between $15.50 and $15.75.
Oct 15, 2024 - UnitedHealth Group rose 5.6% to $544.54 after the health insurance company reported better-than-expected quarterly results.
Revenue in the second quarter increased to $98.9 billion from $92.9 billion, net income fell to $4.4 billion from $5.5 billion, and diluted earnings per share advanced to $4.54 from $5.82 a year ago.
The company adjusted its full-year earnings per share outlook to between $15.95 and $16.40, reflecting the sale of its remaining stake in its South African unit. The company also completed the sale of its large Brazilian operations in the first quarter.
Jul 16, 2024 - UnitedHealth Group soared 6.8% to $478.29 after the insurance company reported better-than-expected earnings on lower-than-expected costs and rising premiums.
Net income in the quarter increased to $5.47 billion from $5.07 billion and diluted earnings per share rose to $5.82 from $5.34 a year ago.
Medical care ratio in the quarter increased to 83.2% from 81.5% a year ago
The insurance company lifted its adjusted annual earnings estimate to between $24.70 and $25.0 from the previous estimate between $24.0 and $25.0.
Jul 14, 2023 - Amedisys agreed to merge with a subsidiary of UnitedHealth Group, upending its plan to just six weeks ago.
The home-healthcare, hospice and high-acuity care provider accepted an all-cash $101 a share or $3.29 billion offer from Optum.
The merger agreement is conditional based on regulatory approval and shareholder approval and customary closing conditions.
On May 3, Amedisys and Option Care Health agreed to combine in an all-stock deal that valued Amedisys at $3.6 billion or $97.38 a share.
On June 5, Optum made an unsolicited offer to acquire Amedisys for $100 a share.
Amedisys board of directors accepted a slightly lower but all-cash deal.
Compensation committee approved one-time equity award grants of time-based restricted stock units that vest ratably over three years.
Amedisys CEO Richard Ashworth will receive $2.5 million grant date value, and CFO Scott Ginn will receive $1.5 million grant date value, effective from the date of merger in exchange for not agreeing to leave the company for six months after the completion of the merger.
Jun 26, 2023
| Year | Mar | Jun | Sep | Dec | Annual | |
|---|---|---|---|---|---|---|
| 2023 | 5.95 | 5.82 | 6.24 | 5.83 | - | |
| 2022 | 5.27 | 5.34 | 5.55 | 5.02 | 21.18 | |
| 2021 | 5.08 | 4.46 | 4.28 | 4.26 | 18.08 | |
| 2020 | 3.52 | 6.91 | 3.3 | 2.3 | 16.03 | |
| 2019 | 3.56 | 3.42 | 3.67 | 3.68 | 14.33 | |
| 2018 | 2.87 | 2.98 | 3.24 | 3.1 | 12.19 | |
| 2017 | 2.37 | 2.46 | 2.66 | 2.59 | 10.08 | |
| 2016 | 1.81 | 1.96 | 2.17 | 2.11 | 8.05 | |
| 2015 | 1.46 | 1.64 | 1.65 | 1.40 | 6.15 | |
| 2014 | 1.10 | 1.42 | 1.63 | 1.55 | 5.7 | |
| 2013 | 1.16 | 1.40 | 1.53 | 1.41 | 5.5 | |
| 2012 | 1.31 | 1.27 | 1.50 | 1.20 | 5.28 | |
| 2011 | 1.22 | 1.16 | 1.17 | 1.18 | 4.73 | |
| 2010 | 1.03 | 0.99 | 1.14 | 0.94 | 4.1 | |
| 2009 | 0.81 | 0.73 | 0.89 | 0.81 | 3.24 | |
| 2008 | 0.78 | 0.27 | 0.75 | 0.60 | 2.4 | |
| 2007 | 0.66 | 0.89 | 0.95 | 0.92 | 3.42 | |
| 2006 | 0.63 | 0.70 | 0.80 | 0.84 | 2.97 | |
| 2005 | 0.55 | 0.58 | 0.61 | 0.57 | 2.31 |